Sanctura Muscarinic Receptor Antagonist Resists Transport (SMART) Trial

Trial Profile

Sanctura Muscarinic Receptor Antagonist Resists Transport (SMART) Trial

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Mar 2016

At a glance

  • Drugs Trospium chloride (Primary)
  • Indications Overactive bladder
  • Focus Pharmacokinetics
  • Acronyms SMART
  • Sponsors Allergan
  • Most Recent Events

    • 16 Sep 2010 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
    • 16 Sep 2010 Actual end date (Aug 2009) added as reported by ClinicalTrials.gov.
    • 14 Apr 2010 Results have been published as an abstract (62nd Annual Meeting of the American Academy of Neurology).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top